New in MMWR: Pneumococcal Vaccination, Suicide Rates, and more

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

This Week in MMWR: Vol. 71, September 16, 2022

September 16, 2022

WEEKLY REPORT

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 On June 22, 2022, the Advisory Committee on Immunization Practices recommended use of PCV15 as an option for pneumococcal conjugate vaccination of persons aged <19 years, according to currently recommended PCV13 dosing and schedules. Risk-based recommendations on use of PPSV23 have not changed.

• Suicides Among American Indian or Alaska Native Persons — National Violent Death Reporting System, United States, 2015–2020
• Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species — United States, January 2016–August 2022
• Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
• Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
• Notes from the Field: Nitazene-Related Deaths — Tennessee, 2019–2021

READ MORE

QUICKSTATS

 

Percentage of Total Deaths, by Age and Hispanic Origin and Race — United States, 2020

PDF of this Issue (link).

CONTINUING EDUCATION

READ MORE

MMWR Weekly Briefing Podcast: Week of September 5

The latest MMWR Weekly Briefing is live. This episode covers six reports, including reports highlighting adoption of prevention strategies and modeling monkeypox spread among men who have sex with men and more Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |